Pancreatic Cancer Research

ResearcherUniversity of LondonNo recent work listed

Charlotte E. Edling

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0959-1455; OpenAlex author ID A5061606928. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper

Papers 3

  1. Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer. Co-author DOI 10.1186/s13046-019-1191-2↗
  2. GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. Co-author DOI 10.1038/s41388-018-0390-1↗
  3. Targeting phosphoinositide 3-kinase pathways in pancreatic cancer--from molecular signalling to clinical trials. Last author DOI 10.2174/187152011795677382↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marco Falasca · 3 shared papers, 2011–2019 · strength 0.19
  2. Riccardo Ferro · 2 shared papers, 2018–2019 · strength 0.15
  3. Stefano Iacobelli · 1 shared paper, 2019 · strength 0.09
  4. Aikaterini Emmanouilidi · 1 shared paper, 2019 · strength 0.09
  5. Aleksandra Adamska · 1 shared paper, 2018 · strength 0.07
  6. Vincenzo De Laurenzi · 1 shared paper, 2018 · strength 0.07
  7. Owen James Sansom · 1 shared paper, 2018 · strength 0.07
  8. Federico Selvaggi · 1 shared paper, 2011 · strength 0.03
  9. Sara Sulpizio · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.